Literature DB >> 12224978

Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus.

Dana R Black1, Carlton A Hornung, Paul D Schneider, Jeffrey P Callen.   

Abstract

OBJECTIVE: To compare the frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus (SCLE) followed up in a dermatology practice vs patients with systemic lupus erythematosus (SLE) followed up in a rheumatology practice.
DESIGN: Case-control comparison of patients matched for age, sex, and ethnicity.
SETTING: University-affiliated dermatology and rheumatology practices. PATIENTS: Seventy-six patients with SCLE were compared with 24 patients with SLE. INTERVENTION: All medical records were reviewed and the patients were interviewed. MAIN OUTCOME MEASURES: Systemic and serologic findings were compared between patients with SCLE and those with SLE.
RESULTS: Hematologic disorders were present in 6 patients (8%) with SCLE and in 13 patients (54%) with SLE (P<.001). Serositis was present in 1 patient (1%) with SCLE and in 3 patients (12%) with SLE (P =.04). Renal involvement was present in 12 patients (16%) with SCLE and in 6 patients (25%) with SLE (P =.36). Antinuclear antibodies were found in 52 patients (68%) with SCLE compared with 23 patients (96%) with SLE (P =.006). Anti-Ro antibodies were found in 37 patients (49%) with SCLE compared with 10 patients (42%) with SLE (P =.64). Other serologic abnormalities (anti-native DNA, anti-Sm antibody, or anti-U(1)RNP) were present in 6 patients (8%) with SCLE compared with 15 patients (62%) with SLE (P<.001). Photosensitivity was present in 65 patients (86%) with SCLE, compared with 11 patients (46%) with SLE (P<.001).
CONCLUSIONS: This analysis reveals a dissimilar frequency of internal organ involvement between patients with SCLE and SLE. Renal disease was similar in frequency and severity, and documented central nervous system involvement was rare in both groups.

Entities:  

Mesh:

Year:  2002        PMID: 12224978     DOI: 10.1001/archderm.138.9.1175

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Amlodipine-induced subacute cutaneous lupus.

Authors:  Alex G Ortega-Loayza; Calvin O McCall; Richard H Cooke; Ion S Jovin
Journal:  N Am J Med Sci       Date:  2013-03

3.  Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).

Authors:  Janice Tiao; Rui Feng; Kasey Carr; Joyce Okawa; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2016-02-18       Impact factor: 11.527

4.  Paraneoplastic cutaneous lupus secondary to esophageal squamous cell carcinoma.

Authors:  Thoyaja Koritala; Joseph Tworek; Brian Schapiro; Eugene Zolotarevsky
Journal:  J Gastrointest Oncol       Date:  2015-06

5.  Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature.

Authors:  Anthony Q Pham; David Berz; Patricia Karwan; Gerald A Colvin
Journal:  Case Rep Oncol       Date:  2011-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.